Terns Pharmaceuticals earnings were -$88.9M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest TERN earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$21.8M, down 0.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TERN reported annual earnings of -$88.9M, with -1.5% growth. The next TERN earnings date is May 12, 2025.
Terns Pharmaceuticals Earnings Reports & History FAQ
What were Terns Pharmaceuticals's earnings last quarter?
On TERN's earnings call on Invalid Date, Terns Pharmaceuticals (NASDAQ: TERN) reported Q4 2024 earnings per share (EPS) of -$0.23, up 20.69% year over year. Total TERN earnings for the quarter were -$21.80 million. In the same quarter last year, Terns Pharmaceuticals's earnings per share (EPS) was -$0.29.
The next TERN earnings call is Invalid Date. Add TERN to your watchlist to be reminded of Terns Pharmaceuticals's next earnings date.
What was TERN's earnings growth in the past year?
As of Terns Pharmaceuticals's earnings date in Invalid Date, Terns Pharmaceuticals's earnings has grown year over year. TERN earnings in the past year totalled -$88.85 million.
Is Terns Pharmaceuticals profitable or losing money?
As of the last Terns Pharmaceuticals earnings report, Terns Pharmaceuticals is currently losing money. Terns Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$88.85 million, a 1.5% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.